Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
Dell’Aquila, E., Cremolini, C., Zeppola, T., Lonardi, S., Bergamo, F., Masi, G., Stellato, M., Marmorino, F., Schirripa, M., Urbano, F., Ronzoni, M., Tomasello, G., Zaniboni, A., Racca, P., Buonadonna, A., Allegrini, G., Fea, E., Di Donato, S., Chiara, S., Tonini, G., Tomcikova, D., Boni, L., Falcone, A., Santini, D.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
Schirripa, M, Bergamo, F, Cremolini, C, Casagrande, M, Lonardi, S, Aprile, G, Yang, D, Marmorino, F, Pasquini, G, Sensi, E, Lupi, C, De Maglio, G, Borrelli, N, Pizzolitto, S, Fasola, G, Bertorelle, R, Rugge, M, Fontanini, G, Zagonel, V, Loupakis, F, Falcone, A
Published in British journal of cancer (09.06.2015)
Published in British journal of cancer (09.06.2015)
Get full text
Journal Article
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
Cremolini, C., Antoniotti, C., Lonardi, S., Bergamo, F., Cortesi, E., Tomasello, G., Moretto, R., Ronzoni, M., Racca, P., Loupakis, F., Zaniboni, A., Tonini, G., Buonadonna, A., Marmorino, F., Allegrini, G., Granetto, C., Masi, G., Zagonel, V., Sensi, E., Fontanini, G., Boni, L., Falcone, A.
Published in Annals of oncology (01.07.2018)
Published in Annals of oncology (01.07.2018)
Get full text
Journal Article
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies
Marmorino, F., Rossini, D., Lonardi, S., Moretto, R., Zucchelli, G., Aprile, G., Dell’Aquila, E., Ratti, M., Bergamo, F., Masi, G., Urbano, F., Ronzoni, M., Libertini, M., Borelli, B., Randon, G., Buonadonna, A., Allegrini, G., Pella, N., Ricci, V., Boccaccino, A., Latiano, T.P., Cordio, S., Passardi, A., Tamburini, E., Boni, L., Falcone, A., Cremolini, C.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Estimating 12-week death probability in patients with refractory metastatic colorectal cancer: the Colon Life nomogram
Pietrantonio, F., Miceli, R., Rimassa, L., Lonardi, S., Aprile, G., Mennitto, A., Marmorino, F., Bozzarelli, S., Antonuzzo, L., Tamburini, E., Morano, F., Rossini, D., Battaglin, F., Baretti, M., Berenato, R., Formica, V., Mosconi, S., Petrelli, F., Ghidini, M., Loupakis, F., Spada, D., Cinieri, S., Beretta, G., Falcone, A., de Braud, F., Cremolini, C.
Published in Annals of oncology (01.03.2017)
Published in Annals of oncology (01.03.2017)
Get full text
Journal Article
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
LOUPAKIS, F, SCHIRRIPA, M, MARMORINO, F, MASI, G, FALCONE, A, CAPARELLO, C, FUNEL, N, POLLINA, L, VASILE, E, CREMOLINI, C, SALVATORE, L, MORVILLO, M, ANTONIOTTI, C
Published in British journal of cancer (25.06.2013)
Published in British journal of cancer (25.06.2013)
Get full text
Journal Article
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer
Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Murgioni, S., Rossini, D., Marmorino, F., Mennitto, A., Ning, Y., Okazaki, S., Berger, M.D., Miyamoto, Y., Gopez, R., Barzi, A., Yamaguchi, T., Loupakis, F., Lenz, H.-J.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies
Rossini, D., Sbrana, A., Bergamo, F., Manai, C., Santini, D., Ghidini, M., Antoniotti, C., Moretto, R., Marmorino, F., Urbano, F., Ronzoni, M., Noventa, S., Randon, G., Carlomagno, C., Latiano, T., Cordio, S., Granetto, C., Cremolini, C., Falcone, A., Antonuzzo, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
TRIBE2: A phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable metastatic colorectal cancer (mCRC) patients (pts)
Cremolini, C., Antoniotti, C., Lonardi, S., Rossini, D., Pietrantonio, F., Cordio, S.S., Murgioni, S., Marmorino, F., Maiello, E., Passardi, A., Masi, G., Tamburini, E., Santini, D., Grande, R., Zaniboni, A., Granetto, C., Loupakis, F., Delliponti, L., Boni, L., Falcone, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Impact of age and gender on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: a pooled analysis of TRIBE and TRIBE2 studies
Zucchelli, G., Marmorino, F., Rossini, D., Aprile, G., Casagrande, M., Lonardi, S., Murgioni, S., Dell’Aquila, E., Tomasello, G., Moretto, R., Antoniotti, C., Borelli, B., Urbano, F., Ronzoni, M., Zaniboni, A., Manglaviti, S., Buonadonna, A., Ritorto, G., Masi, G., Allegrini, G., Falcone, A., Cremolini, C.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Updated results of TRIBE2, a phase III, randomized strategy study by GONO in the 1st- and 2nd-line treatment of unresectable mCRC
Cremolini, C., Antoniotti, C., Lonardi, S., Rossini, D., Morano, F., Cordio, S., Bergamo, F., Marmorino, F., Maiello, E., Passardi, A., Masi, G., Tamburini, E., Santini, D., Grande, R., Zaniboni, A., Granetto, C., Murgioni, S., Aprile, G., Delliponti, L., Boni, L., Falcone, A.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Molecular characterization of immune microenvironment in colorectal cancers with microsatellite instability by digital RNA counting
Giordano, M., Moretto, R., Giannini, R., Zucchelli, G., Pietrantonio, F., Antoniotti, C., Ugolini, C., Morano, F., Marmorino, F., Sensi, E., Belfiore, A., Rossini, D., Lupi, C., Masi, G., Borelli, B., Ongaro, E., Boccaccino, A., Falcone, A., Cremolini, C., Fontanini, G.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO
Marmorino, F., Cremolini, C., Bergamo, F., Pella, N., Antoniotti, C., Rossini, D., Dell'Aquila, E., Masi, G., Salvatore, L., Loupakis, F., Marcucci, L., Gemma, D., Cardellino, G., Borelli, B., Ricci, V., Delfanti, S., Mori, E., Tonini, G., Lonardi, S., Fontanini, G., Boni, L., Falcone, A.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Circulating angiogenesis-related markers as predictors of benefit from regorafenib in metastatic colorectal cancer (mCRC) patients (pts)
Antoniotti, C., Marmorino, F., Pennati, M., Zaffaroni, N., Rossini, D., Borelli, B., Zucchelli, G., Moretto, R., Pietrantonio, F., Masi, G., Vannini, F., Colombo, C., Saettini, A., Gini, S., Delliponti, L., Pfanner, E., Brunetti, I., Falcone, A., Cremolini, C.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial
Dell'Aquila, E., Pantano, F., Rossini, D., Stellato, M., Lonardi, S., Masi, G., Schirripa, M., Marmorino, F., Antoniotti, C., Murgioni, S., Tomasello, G., Ronzoni, M., Racca, P., Vincenzi, B., Allegrini, G., Urbano, F., Buonadonna, A., Banzi, M., Tonini, G., Cremolini, C., Falcone, A., Santini, D.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC)
Ongaro, E., Rossini, D., Pietrantonio, F., Morano, F., de Braud, F., Mazzaferro, V., Corti, F., Randon, G., Raimondi, A., Battaglia, L., Morelli, L., Urbani, L., Masi, G., Moretto, R., Antoniotti, C., Marmorino, F., Borelli, B., Zucchelli, G., Boccaccino, A., Cremolini, C., Falcone, A.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Histopathologic response and growth patterns of colorectal cancer liver metastases (CRCLM) in patients treated with triplets plus bevacizumab (bev) or anti-EGFRs
Marmorino, F., Cremolini, C., Pietrantonio, F., Pellegrinelli, A., Zucchelli, G., Loupakis, F., Lonardi, S., Aprile, G., Morano, F., Prisciandaro, M., Masi, G., Mennitto, A., Bergamo, F., Cardellino, G.G., Fassan, M., Casagrande, M., Milione, M., Fontanini, G., de Braud, F., Falcone, A.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients
Puccini, A., Grillo, F., Fassan, M., Lonardi, S., Genuardi, M., Cannizzaro, R., Cavestro, G.M., Marmorino, F., Conca, V., Salvatore, L., Bergamo, F., Tosi, F., Morano, F., Daprà, V., Molica, C., Barana, D., Guglielmi, A., Signorelli, C., D’Amico, M., Zoratto, F., Iacono, D., Morabito, A., Martini, G., Fabbroncini, A., Duro, M., Bruera, G., Auriemma, A., Bonanni, B., Percesepe, A., Dono, M., Battistuzzi, L., Labianca, R., Boni, L., Sciallero, S.
Published in ESMO Gastrointestinal Oncology (01.03.2024)
Published in ESMO Gastrointestinal Oncology (01.03.2024)
Get full text
Journal Article
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab
Falvella, F S, Cremolini, C, Miceli, R, Nichetti, F, Cheli, S, Antoniotti, C, Infante, G, Martinetti, A, Marmorino, F, Sottotetti, E, Berenato, R, Caporale, M, Colombo, A, de Braud, F, Di Bartolomeo, M, Clementi, E, Loupakis, F, Pietrantonio, F
Published in The pharmacogenomics journal (01.07.2017)
Published in The pharmacogenomics journal (01.07.2017)
Get full text
Journal Article
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials
Dell’Aquila, E., Rossini, D., Fulgenzi, C.A.M., Passardi, A., Tamburini, E., Vetere, G., Carullo, M., Citarella, F., Antoniotti, C., Zaniboni, A., Pietrantonio, F., Spagnoletti, A., Marmorino, F., Borelli, B., Allegrini, G., Lonardi, S., Nappo, F., Masi, G., Cremolini, C., Santini, D.
Published in ESMO open (01.12.2022)
Published in ESMO open (01.12.2022)
Get full text
Journal Article